Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 36.96M | $153.0M | 8.16% | +5.88M | 2026-06-30 |
| STATE STREET CORP | 24.48M | $101.0M | 5.40% | +7.03M | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 19.01M | $79.0M | 4.20% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 18.20M | $75.0M | 4.02% | +1.59M | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 14.39M | $59.0M | 3.18% | +2.69M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 10.32M | $42.0M | 2.28% | +1.75M | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 8.53M | $35.0M | 1.88% | -888.4K | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 6.46M | $26.0M | 1.43% | +3.81M | 2026-06-30 |
| JANE STREET GROUP, LLC | 5.47M | $22.0M | 1.21% | +788.9K | 2026-06-30 |
| Palo Alto Investors LP | 5.30M | $22.0M | 1.17% | -1.05M | 2026-06-30 |
